Treatment of Aregeneratoric Anemia Following an ABO‐Incompatible Allogeneic Peripheral Blood Stem Cell Transplantation: A Case Report-Reference-Cited by-同舟云学术

Treatment of Aregeneratoric Anemia Following an ABO‐Incompatible Allogeneic Peripheral Blood Stem Cell Transplantation: A Case Report

Published:1999-08 Issue:3 Volume:3 Page:275-277
ISSN:1091-6660
Container-title:Therapeutic Apheresis
language:en
Short-container-title:Therapeutic Apheresis

Author:

Üstün Celalettin¹,Çelebi Harika¹,Arat Mutlu¹,Özcan Muhit¹,Dilek İmdat¹,Gürman Günhan¹,Demirer Taner¹,İlhan Osman¹,Keskin Remzi¹,Koç Haluk¹

Affiliation:

1. Department of Hematology/Oncology and Bone Marrow Transplant Unit, İbn‐i Sina Hospital, Medical School, Ankara University, Ankara, Turkey

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1526-0968.1999.00135.x

Reference13 articles.

1. LongGD&BlumeKG. Allogeneic and autologous marrow transplantation. In: Beutler E Lichtman MA Coller BS Kipps TJ eds.Williams' Hematology. International edition. New York: McGraw Hill 1995: 172–94.

2. Pure Red-Cell Aplasia of Long Duration after Major ABO-Incompatible Bone Marrow Transplantation

3. Pure red cells aplasia complicating an ABO‐compatible allogeneic bone marrow transplantation, treated successfully with antithymocyte globulin.;Roychowdhury DF;Bone Marrow Transplant,1995

4. PaltielO CournoyerD RybkaW.Pure red cell aplasia following ABO‐incompatible bone marrow transplantation: Response to rEPO.Transfusion1993;33:41821.

5. Antilymphocyte globulin for treatment of pure red cell aplasia after major ABO incompatible marrow transplant.;Labar B;Bone Marrow Transplant,1992

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pure red cell aplasia after major or bidirectional ABO incompatible hematopoietic stem cell transplantation: to treat or not to treat, that is the question;Bone Marrow Transplantation;2020-11-14

2. Immunosuppressive treatment in patient with pure red cell aplasia associated with chronic myelomonocytic leukemia: harm or benefit?;International Journal of Hematology;2009-09-18

3. Prevention of pure red cell aplasia after major or bidirectional ABO blood group incompatible hematopoietic stem cell transplantation by pretransplant reduction of host anti-donor isoagglutinins;Haematologica;2009-01-14

4. rhEPO in hematopoietic stem cell transplantation;Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology;2008

5. Therapeutic Plasma Exchange;Blood Banking and Transfusion Medicine;2007